LLS Launches “Call for Cures”
The Leukemia & Lymphoma Society recently launched an important organization called Call for Cures. This is a “virtual” march on Capitol Hill which focuses on influencing elected officials online and in each person’s home states and cities. Their efforts will focus on two main issues: Cures Acceleration Network (CAN) and the effort to get September declared by Congress as “Blood Cancer Awareness Month.”
Certainly, this is one of the many ways that the Leukemia & Lymphoma Society is working to get its important messages heard. Donations from those like Corey Ribotsky and the NIR Group, advocacy and active support all help in the fight again cancer.
Investments During Deflation: Corey Ribotsky
This interesting piece lays the ground work for the best investments during deflation. Many investment managers are worried about deflation and it’s certainly worthwhile to have a handle on the best investment strategies at such a time. Everyone from fund managers and experts like Corey Ribotsky to the simple private investor can benefit from these astute suggestions.
Investing News with Corey Ribotsky
Here’s an interesting analysis for investors out there. This post tries to explain the low options trading volumes we are seeing at the moment. It’s certainly an interesting analysis of the complete nuance of the stock market and of investment portfolios that is worth a read for anyone in the business, such as Corey Ribotsky of the NIR Group.
As the article ends, he states, “This exacerbates the low options and stock trading volumes, which makes it even more difficult for investors to conclude that this stretch of the tape is decisively bullish, or bearish.”
The Recent European Stress Test
This short piece at CNBC.com offers a concise and articulate analysis of the recent European stress test that banks underwent. As John Carney, Senior Editor at CNBC.com states, “In short, what the stress tests unarguably demonstrated was not that Europe banks are healthy—that’s still arguable—but that regulators view them as healthy and won’t be enforcing any new, drastic rounds of capital raising anytime soon.
They were a test of regulatory forbearance and forbearance won.”
Many investors, from the novice to the experienced managing member like Corey Ribotsky, could find this piece interesting and its advice telling.